Health Technology · Pharmaceuticals: Major · NSE: ALBERTDAVD · data 2026-10-09
Albert David Ltd
Health check: Average (6.2/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹791.65
Market cap
₹457 cr
P/E
20
P/B
—
ROE
-0.4%
ROCE
0.3%
Debt / equity
0.08
Dividend yield
0.62%
1-year return
-1.5%
52-week high
₹931.85
52-week low
₹579.9
Operating margin
4.7%
Growth
| Revenue (last 12 months) | ₹364 cr |
| Net profit (last 12 months) | ₹23 cr |
| Sales growth, 3 years (yearly) | -0.8% |
| Profit growth, 3 years (yearly) | — |
Chart patterns
- Head and shoulders — forming (key level ₹771.5)
Similar companies
Valiant Laboratories Ltd. (VALIANTLAB) · Praveg Limited (PRAVEG) · Infinium Pharmachem Ltd. (INFINIUM) · Medicamen Biotech Limited (MEDICAMEQ) · Jenburkt Pharmaceuticals Ltd (JENBURPH)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open ALBERTDAVD in NSE Scanner →